Wuhan Hvsen Biotechnology Co Ltd (300871) — Cash Flow Reinvestment Rate
Wuhan Hvsen Biotechnology Co Ltd (300871) has a Cash Flow Reinvestment Rate of 0.32x as of September 2025, reinvesting CN¥18.73 Million (capex CN¥18.73 Million ) from operating cash flow of CN¥59.06 Million. Explore Wuhan Hvsen Biotechnology Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Hvsen Biotechnology Co Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Wuhan Hvsen Biotechnology Co Ltd across 10 annual periods. Also explore Wuhan Hvsen Biotechnology Co Ltd (300871) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Wuhan Hvsen Biotechnology Co Ltd. For live market cap and broader valuation context, see market value of Wuhan Hvsen Biotechnology Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | CN¥138.60 Million | CN¥238.45 Million | CN¥96.92 Million | ▼ -91.2% |
| 2024 | 6.58x | CN¥286.61 Million | CN¥43.53 Million | CN¥194.43 Million | ▲ +115.0% |
| 2023 | 3.06x | CN¥284.62 Million | CN¥92.92 Million | CN¥184.31 Million | ▼ -61.0% |
| 2022 | 7.85x | CN¥758.87 Million | CN¥96.68 Million | CN¥428.87 Million | ▲ +21.0% |
| 2021 | 6.49x | CN¥1.01 Billion | CN¥155.72 Million | CN¥600.12 Million | ▼ -53.2% |
| 2020 | 13.87x | CN¥670.84 Million | CN¥48.35 Million | CN¥230.84 Million | ▲ +159.3% |
| 2019 | 5.35x | CN¥563.06 Million | CN¥105.24 Million | CN¥123.06 Million | ▼ -76.2% |
| 2018 | 22.47x | CN¥474.05 Million | CN¥21.10 Million | CN¥34.05 Million | ▲ +264.7% |
| 2017 | 6.16x | CN¥496.40 Million | CN¥80.56 Million | CN¥56.40 Million | ▲ +1222.0% |
| 2016 | 0.47x | CN¥27.97 Million | CN¥60.00 Million | CN¥27.97 Million | — |